Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
CzechiaEvaluation of Blomia tropicalis allergen extract using skin-prick test in patients with allergies
SpainStudy of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment
BelgiumStudy of MK-8527 taken once monthly compared to emtricitabine/tenofovir taken daily for HIV-1 prevention
FranceSafety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema
GermanyStudy of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis
GermanyStudy of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose
GermanyComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
AustriaStudy of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis
BelgiumStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
AustriaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
CroatiaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
